Pioglitazone induces regression and stabilization of coronary atherosclerotic plaques in patients with impaired glucose tolerance
Diabetic Medicine,  Clinical Article

Yang HB et al. – Pioglitazone may induce regression and stabilization of coronary atherosclerotic plaques. The mechanisms might involve inhibition of inflammation, increase in adiponectin level and improvement in endothelial function.

  • Thirty patients were randomly divided into two groups: a pioglitazone group and a control group.
  • The latter was administered placebo in addition to standard therapy; the former pioglitazone 15mg/d in addition to standard therapy.
  • Before treatment and 6months later, left ventricular ejection fraction, serum lipid profile, high–sensitivity C–reactive protein, adiponectin and plasma endothelin–1 levels were detected.
  • Coronary plaque area and plaque burden were examined using intravascular ultrasound.

  • No significant differences were found in left ventricular ejection fraction and serum lipid levels pre– and post–trial.
  • Compared with the control group, 6months' treatment with pioglitazone significantly decreased coronary plaque burden (50.7±11.1 vs. 64.1±10.3%, P<0.05), plaque area (6.22±2.03 vs. 8.31±4.29, P<0.05), thin–cap fibroatheroma prevalence (11 vs. 22%, P<0.05) and percentage of necrotic core area (16±8 vs. 31±7%, P<0.05).
  • Compared with the control group, serum high–sensitivity C–reactive protein and plasma endothelin–1 levels were significantly lower and adiponectin level significantly higher in patients in the pioglitazone group.
  • Serum adiponectin level was negatively correlated with plasma endothelin–1 level and coronary plaque area (r=0.739 and –0.431, respectively, both P<0.05).

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx


Most Popular Internal Medicine Articles

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Make smarter career moves with less time.

Sign up for our free job placement service today and have a dedicated career consultant help locate the right physician job for you!
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List